Doctor's Bio
Board Certifications
American Board of Surgery
Affiliations
Emory
Education & Training
- Medical School: Baylor College of Medicine
- Internship: Baylor College of Medicine
- Residency: New York University
Locations and Directions
Grady Memorial Hospital
Phone: (404) 616-1000
Location:
80 Jesse Hill Jr Drive SE
Atlanta, GA 30303
Publications
- Toggling of NKG2A expression drives functional specialization of iPSC-derived CAR NK cells.
Kanaya M, Philippon C, Netskar H, Saetersmoen ML, Cieslar-Pobuda A, Torralba-Raga L, Casoni GP, Hammer Q, Vincenti M, Wiiger MT, Krokeide SZ, Hoel HJ, Ask EH, Kosugi-Kanaya M, Kveberg L, Chu HY, Groff B, Miller JS, Lee T, Kaufman DS, Goodridge JP, Valamehr B, Pfefferle A, Malmberg KJ
bioRxiv : the preprint server for biology. 2025;
PMID: 40894717 - Chronic NK cell activation results in a dysfunctional, tissue resident-like state mediated by KLF2 deficiency.
Myers J, Huang RS, Phung SK, Chacón JM, Bendzick LE, Weis AJ, Shetty M, DePauw T, Khaw MJ, Abrahante Llorens JE, O'Flanagan SD, Ashby KM, Lozada JR, Jameson SC, Hwang JH, Cichocki F, Felices M, Miller JS
Blood. 2025;
PMID: 40857665 - The transcription factor BCL11B drives NK cell cytotoxicity and antitumor activity.
Kumar A, Zhang B, Baldys A, Fischer C, Lenvik A, Felices M, Davis ZB, Bendzick L, Weis AJ, Bryceson YT, Miller JS, Cichocki F
Journal of immunology (Baltimore, Md. : 1950). 2025;
PMID: 40838628 - Correction: Natural killer cell infiltration in prostate cancers predict improved patient outcomes.
Zorko NA, Makovec A, Elliott A, Kellen S, Lozada JR, Arafa AT, Felices M, Shackelford M, Barata P, Zakharia Y, Narayan V, Stein MN, Zarrabi KK, Patnaik A, Bilen MA, Radovich M, Sledge G, El-Deiry WS, Heath EI, Hoon DSB, Nabhan C, Miller JS, Hwang JH, Antonarakis ES
Prostate cancer and prostatic diseases. 2025;
PMID: 40796671 - Multiplexed iPSC platform for advanced NK cell immunotherapies.
Kumar A, Fischer C, Cichocki F, Miller JS
Cell reports. Medicine. 2025;
PMID: 40780202 - Novel trispecific killer engager targeting B7-H3 enhances natural killer cell antitumor activity against head and neck cancer.
Khaw MJ, Zorko NA, Kennedy PR, Bendzick LE, Shackelford M, Selleck C, Hinderlie P, Walker JT, Soignier Y, Lyons RC, Femino EL, Stenger T, Dasgupta T, Kotz LE, Shetty M, Phung SK, Lee EH, Lu Q, Lim J, Provenzano PP, Fujioka N, Davis ZB, Geller MA, Wagner JE, MacMillan ML, Felices M, Miller JS
Journal for immunotherapy of cancer. 2025;
PMID: 40707133 - Inflammasome-resistant IPSC-derived myeloid-derived suppressor cells ameliorate xenogeneic graft-versus-host disease.
Ma L, Koehn BH, Zaiken MC, Hippen KL, Smith KD, Allred JR, Williams RL, Yao K, Fink J, Saha A, Kopp B, Payne N, Widelak R, Panoskaltsis-Mortari A, Riddle MJ, Tolar J, Eide C, Xia L, Witty AD, Mehta AK, Denholtz M, Hefazi M, Hani S, Kenderian SS, Miller JS, Molldrem JJ, Kean LS, Valamehr B, Blazar BR
Blood. 2025;
PMID: 40700578 - Impact of the IL-15 superagonist N-803 on lymphatic reservoirs of HIV.
Rhein J, Chipman JG, Beilman GJ, Cromarty R, Escandón K, Anderson J, Wieking G, Reichel J, Batres R, Khoruts A, Basting CM, Hinderlie P, Davis ZB, Eaton A, Vaughn BP, Eilkhani E, Safrit JT, Soon-Shiong P, Baker JV, Klatt NR, Deeks SG, Miller JS, Schacker TW
JCI insight. 2025;
PMID: 40471871 - Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: a first-in-human, single-centre, phase 1 trial.
Lou E, Choudhry MS, Starr TK, Folsom TD, Bell J, Rathmann B, DeFeo AP, Kim J, Slipek N, Jin Z, Sumstad D, Klebanoff CA, Ladner K, Sarkari A, McIvor RS, Murray TA, Miller JS, Rao M, Jensen E, Ankeny J, Khalifa MA, Chauhan A, Spilseth B, Dixit A, Provenzano PP, Pan W, Weber D, Byrne-Steele M, Henley T, McKenna DH, Johnson MJ, Webber BR, Moriarity BS
The Lancet. Oncology. 2025;26(5):559-570.
PMID: 40315882 - Chimeric antigen receptor therapies: Development, design, and implementation.
Lee MJ, Cichocki F, Miller JS
The Journal of allergy and clinical immunology. 2025;156(1):70-80.
PMID: 40220909
PLANNING
PREPARING FOR YOUR VISIT
Whether you’re a patient or you’re visiting one, a little planning beforehand can make your visit to Grady easier and more comfortable. Here, you’ll find everything you need to prepare for your visit, including an appointment checklist, admissions information, dining options, and much more.